-
February 1 Is A Huge Day For Tech Earnings
Thursday, January 25, 2018 - 12:32pm | 818Regardless of analyst forecasts or political headlines, there’s no catalyst for stocks quite like earnings season. And the first earnings season of the year, which we’re just now getting into the heart of, can often set the tone for the entire year. No day will encapsulate this better...
-
3 Factors That Can Help Determine If A Stock Will Outperform Or Underperform
Friday, December 15, 2017 - 4:34pm | 663Even in a bull market as relentless as the one we're currently in, it can still be hard to predict markets and time trades. For example, who could have predicted Amazon.com Inc (NASDAQ: AMZN) would buy Whole Foods? Or that bitcoin would become the highest flyer of the year? We can’t...
-
Different Options Strategies For Different Traders
Friday, November 24, 2017 - 12:29pm | 489Options trading can be a very profitable trading technique, but it requires a certain level of comfort and knowledge of the market. Despite that, there are options strategies that traders with different amounts of experience—and differing appetites for risk—can use to make a solid buck...
-
How To Use Options During Earnings Season
Thursday, October 12, 2017 - 10:25am | 735Earnings season and options trading go together like Amazon.com (NASDAQ: AMZN) and Whole Foods. Or Microsoft Corporation (NASDAQ: MSFT) and LinkedIn. Or Gilead Sciences, Inc. (NASDAQ: GILD) and Kite Pharma. You get the idea. The binary nature of an earnings event—either Wall Street likes the...
-
Biogen's Core Business Impresses While Potential Alzheimer's Catalyst Looms
Thursday, October 5, 2017 - 10:54am | 331Analysts at Morgan Stanley turned bullish on Biogen Inc (NASDAQ: BIIB) as the company's phase 3 Alzheimer's catalyst could "make all its potential issues disappear." The firm's Matthew Harrison upgraded Biogen's stock rating from Equal-Weight to Overweight with a price target boosted from $311 to $...
-
Expect More Downside In Axovant Sciences
Thursday, October 5, 2017 - 10:45am | 403Shares of Axovant Sciences Ltd (NASDAQ: AXON) plummeted more than 70 percent after the company's late-stage trial involving its therapy for the treatment of Alzheimer's failed to meet its primary objectives in a phase 3 study called MINDSET. Investors thinking Axovant's stock can't see any...
-
Investors Are Overestimating The Near-Term Benefit To GrubHub's Earnings From Eat24
Thursday, October 5, 2017 - 10:32am | 301Citigroup downgraded shares of GrubHub Inc (NYSE: GRUB), as it believes the recent run up in shares is now reflecting the near-term outlook. The firm noted that GrubHub shares have gained 44 percent in the year-to-date period and has added 12 percent or $6 per share since it announced the...
-
Momenta Pharma Could Face Pressure Following Approval Of Mylan's Generic Copaxone
Thursday, October 5, 2017 - 8:58am | 435The U.S. Food and Drug Administration's approval of Mylan N.V. (NASDAQ: MYL)'s generic version of Copaxone for the treatment of relapsing multiple sclerosis should be seen as a "clear negative" for Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA)'s Glatopa franchise, analysts at Baird said. The firm's...
-
A Look At September's Strong Auto Sales
Wednesday, October 4, 2017 - 2:45pm | 347Investors were treated with particularly strong auto sales data this week as September U.S. light vehicle SAAR (seasonally adjusted annualized rate) read 18.6 million, which was notably higher than the consensus estimate of 17.4 million. September's SAAR reading also happens to be the strongest...
-
When Should You Take A Slice Of Domino's Pizza Stock?
Wednesday, October 4, 2017 - 11:51am | 445While viewing Domino's Pizza, Inc. (NYSE: DPZ) as still hot, Credit Suisse feels competition could eventually take a bite out of the company. Therefore, the firm indicated now might not be the right time to invest in the company's shares. As such, the firm initiated coverage of Domino's...
-
How One Woman Rebuilt Her Portfolio After Losing Nearly Half Of It During The Financial Crisis
Wednesday, September 13, 2017 - 4:26pm | 801After the 2008 financial crisis, Sandy Chaikin lost almost half of her 401(k) portfolio. She has a similar story to many Americans: she had faith in her portfolio manager and trusted the advice she was given to not sell through the worst periods of the crash. After betraying her better judgment for...
-
3 Things To Consider Before You Make An Options Trade
Monday, August 28, 2017 - 3:42pm | 524Trading options are a potentially valuable way for traders to double down on profitable trades and protect themselves from risk. While options are a somewhat complex trading technique, it’s not difficult for even beginner traders to pick up options strategies that work for them. What’...
-
Marc Chaikin Launches The 'Pandora Of Fintech' Stock Discovery Engine
Thursday, June 29, 2017 - 8:41am | 277The market collapse of 2008 inspired great change in American financial habits, no less in those of Marc Chaikin. Chaikin emerged from retirement to found and lead Chaikin Analytics, a fintech company guiding individual and institutional investors toward objective, unbiased stock investments. He...
-
Chaikin Analytics Solves One Of The Biggest Problems For Traders
Tuesday, June 27, 2017 - 1:48pm | 386The 2017 Benzinga Global Fintech Awards saw some of the most innovative companies in fintech show off their products to high-profile financial executives and fintech leaders. Here, we’re sharing the fintech insights and new products on display at this year’s BZ Awards. The Company:...
-
Marc Chaikin's Bullish Thesis On 3 Small-Cap Tech Stocks
Tuesday, May 16, 2017 - 3:31pm | 834This earnings season has been a mixed bag for many of the big name technology and semiconductor companies. NVIDIA Corporation (NASDAQ: NVDA) surprised analysts with impressive sales for the first quarter, but Advanced Micro Devices, Inc. (NASDAQ: AMD) and International Business Machines Corp. (NYSE...